May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
Newly Synthesized Potent ROCKII Inhibitor Isoquinolinesulfonamide Derivative Remarkably Reduces Intraocular Pressure in Cynomologus Monkey and Rabbit
Author Affiliations & Notes
  • Y. Uji
    Ophthalmology, Mie Univ School of Medicine, Tsu, Japan
  • M. Nishio
    D. Western Therapeutics Institute, Inc., Nagoya, Japan
  • T. Fukunaga
    Ophthalmology, Mie Univ School of Medicine, Tsu, Japan
  • Y. Nishimura
    D. Western Therapeutics Institute, Inc., Nagoya, Japan
  • K. Sumi
    D. Western Therapeutics Institute, Inc., Nagoya, Japan
  • K. Takahashi
    D. Western Therapeutics Institute, Inc., Nagoya, Japan
  • Y. Inoue
    D. Western Therapeutics Institute, Inc., Nagoya, Japan
  • H. Hidaka
    D. Western Therapeutics Institute, Inc., Nagoya, Japan
  • Footnotes
    Commercial Relationships  Y. Uji, None; M. Nishio, D. Western Therapeutics Institute, Inc., E; T. Fukunaga, None; Y. Nishimura, D. Western Therapeutics Institute, Inc., E; K. Sumi, D. Western Therapeutics Institute, Inc., E; K. Takahashi, D. Western Therapeutics Institute, Inc., E; Y. Inoue, D. Western Therapeutics Institute, Inc., E; H. Hidaka, D. Western Therapeutics Institute, Inc., P.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 3822. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Y. Uji, M. Nishio, T. Fukunaga, Y. Nishimura, K. Sumi, K. Takahashi, Y. Inoue, H. Hidaka; Newly Synthesized Potent ROCKII Inhibitor Isoquinolinesulfonamide Derivative Remarkably Reduces Intraocular Pressure in Cynomologus Monkey and Rabbit. Invest. Ophthalmol. Vis. Sci. 2008;49(13):3822. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose:
 

Recently, ROCK inhibitor had shown that it could be one of the novel candidates of the glaucoma therapy. ROCK inhibitor lowered intraocular pressure by modulating the morphology of the trabecullar meshwork cells which upregulates the aqueous humor outflow facility through the Schlemm’s canal. We have been developing the isoquinolinesulfonamide derivatives as a ROCK inhibitor and reported that H-1152P, one of the derivatives, had potent inhibitory action for ROCKII. Lately we succeeded in synthesizing a new potent ROCKII inhibitor isoquinolinesulfonamide derivative.

 
Methods:
 

The inhibitory effect on ROCKII of this new compound was measured, and the effects on the intraocular pressure were studied by the instillation in normal Cynomologus monkey, New Zealand White rabbit and Dutch belt rabbit.

 
Results:
 

This compound inhibited ROCKII with IC50 value of 18.7 nM, and its instillation remarkably reduced intraocular pressure during several hours in Cymologus monkey (as shown in Fig) and rabbit, These effects on intraocular pressure were dose-dependently.

 
Conclusions:
 

The results indicate the potential use of this newly synthesized compound as an ocular hypotensive agent.  

 
Keywords: intraocular pressure • drug toxicity/drug effects • enzymes/enzyme inhibitors 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×